source
- Beam Therapeutics files lawsuit accusing former scientist of stealing IP to launch Chinese biotech ventureBeam Therapeutics has initiated legal action alleging that a former employee misappropriated proprietary gene-editing technology. The company claims the scientist used the stolen information to co…
- Merck reports positive phase 2b results for anti-TL1A antibody in hidradenitis suppurativaMerck announced that its experimental anti-TL1A antibody achieved a positive outcome in a phase 2b study. The trial enrolled patients with moderate to severe hidradenitis suppurativa, a chronic in…